Investigators
The following list of investigators have active research in some aspect of drug discovery.
| Investigator | Research Focus | Department | |
|---|---|---|---|
| Burns Blaxall, Ph.D. | Pharmacologic treatments for heart failure | Medicine | |
| Rashid Deane, Ph.D. | Small molecule therapeutics for neurodegenerative diseases, including Alzheimer's disease | Neurosurgery | |
| Paul Dunman, Ph. D. | High throughput screening for novel anti bacterial agents | Microbiology & Immunology | |
| Rudi Fasan, Ph. D. | Chemo-enzymatic synthesis of natural product derivatives with anticancer and antimalarial activity | Chemistry | |
| Jonathan Friedberg, M.D. | Kinase inhibitors for treatment of Iymphoma | Medicine | |
| Harris Gelbard, M. D. | Development of drugs for age-related and inflammatory diseases that target ancient caloric restriction pathways | Neurology | |
| David Goldfarb, Ph.D. | High throughput identification and development of novel lifespan extending compounds | Biology | |
| Craig Jordan, Ph.D. | Novel small molecules to selectively target leukemia cells | Medicine | |
| Karl Kieburtz, M.D. | Human clinical studies of novel therapeutics for various diseases | Neurology | |
| Baek Kim, Ph.D. | Ribonucleotide-based inhibitors of HIV-1 RT; Akt inhibitors for eradication of HIV-1 infection in macrophages" |
Microbiology & Immunology | |
| Damian Krysan, Ph.D. | Antifungal drug discovery | Pediatrics | |
| Hartmut Land, Ph.D. | Gene interactions in oncogenesis | Biomedical Genetics | |
| Joe Miano, Ph.D. | Small molecule inhibitors of genes that regulate pathologic blood vessel contraction | Medicine | |
| Ben Miller, Ph.D. | Chemical synthesis of small molecule ligands; novel RNA-directed therapies for HIV/AIDS | Dermatology | |
| Alan Smrcka, Ph.D. | High throughput identification of novel inhibitors of G beta gamma signaling | Pharmacology & Physiology | |
| Harold Smith, Ph.D. | Small molecule drugs targeting HIV-1 Vif and APOBEC3G | Biochemistry & Biophysics | |
| Harry Stern, Ph.D. | Small molecule docking and affinity calculations | Chemistry | |
| Charles Thornton, M.D. | Novel therapeutics targeting triplet repeat transcripts for treatment of myotonic muscular dystrophy | Neurology | |
| Joseph Wedekind, Ph.D. | Structural analysis of HIV-1 Vif and APOBEC3G | Biochemistry & Biophysics |




